Cleaner by Design: SaniSure Introduces PETG PharmaTainer™ Ultra-Clean Bottles & Carboys

(BUSINESS WIRE) -- SaniSure® today announced the launch of PETG PharmaTainer™, a new line of bioprocessing bottles and carboys combining widely accepted, medical-grade Eastman Eastar® PETG 6763 resin (DMF#9987) with SaniSure’s proprietary process and advanced automation. This launch expands SaniSure’s established PharmaTainer® platform—extending its proven cleanliness, robustness, and performance attributes to include industry-standard PETG alongside its existing PET and PC offerings.

Available in volumes from 10 mL stability vials to 10 L carboys — in sterile (gamma-irradiated) and non-irradiated configurations — PETG PharmaTainer supports the full bioprocessing workflow. Standard and fully custom assemblies with Cap2V8® closures and Cellgyn™ TPE tubing are available for both open and closed operations. Start with PharmaTainer in early-stage R&D and carry the same platform through clinical and commercial phases — eliminating the need for requalification when scaling.

For part numbers, ordering information, and technical specifications, visit sanisure.com/petg or contact your SaniSure representative.

“With PETG PharmaTainer™, we are shifting cleanliness from a post-processing step to a fully automated, built-in standard - enabling us to confidently deliver the cleanest bioprocessing containers on the market for our customers’ most critical applications. Our bottles provide the lowest possible levels of particulates, endotoxins and RNase/DNase - by design - while minimizing adoption timelines.”
— Steven Chevillotte, CEO of SaniSure®

Cleaner by Design: What Sets PETG PharmaTainer™ Apart

Our PETG PharmaTainer delivers a validated suite of cleanliness and compliance attributes consistent with those of our PET and PC bottles:

• Ultra-Low Particle Levels: Certified to less than 5% of USP <788> limits for sub-visible particulates, tested at lot release — no post-wash required.

• Exceptional Endotoxin Control: Results consistently below 0.001 EU/mL detection limit per USP <85> — achieved by design, not by washing.

• RNase/DNase-Free Certified: Validated for nucleic acid-based therapies including mRNA, oligonucleotides, and gene therapy applications requiring contamination-critical containers.

• Ready-to-Use — Sterile: Gamma-sterilized to SAL 10⁻⁶, minimizing the 2–3 days of washing, depyrogenation, and sterilization steps typically required with competitive products, reducing labor and contamination risk.

• Freeze-Thaw Validated to −80°C: Suited for bulk drug substance cold chain, stability studies, and frozen intermediates across the full temperature range.

• Drop-In PETG Replacement: One-to-one volume and format compatibility with legacy PETG bioprocessing bottles; a comparability guide and dedicated technical support are included to minimize change-control burden.

About SaniSure®

As a trusted Single-Use Technologies (SUT) expert, SaniSure brings deep expertise in complex flow paths and closed-system design - supporting the most demanding bioprocessing and advanced therapy workflows. In addition to the PETG PharmaTainer, SaniSure provides a wide array of high-quality components, custom assemblies and SUT solutions.

Where larger organizations often lack flexibility and smaller providers lack scale, SaniSure delivers the best of both - combining agility with end-to-end capabilities and deep vertical integration to help customers de-risk, scale, and innovate.

Learn more at sanisure.com

View source version on businesswire.com: https://www.businesswire.com/news/home/20260420641769/en/